Speaker
Kelly Lindblom, PhD, RAC and David Jensen PhD, RAC
Discuss FDA's approach to regulation of devices in clinical studies and for marketing Provide guidance on when the IDE regulations apply and discuss possible exemptions Review significant risk and non-significant risk device studies Discuss the preparation, submission, and maintenance of IDE applications Encourage participant discussion of case scenarios • Encourage participant discussion of case scenarios